Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$2.24 - $4.76 $1,682 - $3,574
-751 Reduced 6.87%
10,183 $23,000
Q4 2022

Feb 14, 2023

SELL
$2.17 - $35.84 $41,744 - $689,454
-19,237 Reduced 63.76%
10,934 $38,000
Q3 2022

Nov 18, 2022

BUY
$18.3 - $37.02 $30,451 - $61,601
1,664 Added 5.84%
30,171 $1.12 Million
Q2 2022

Aug 15, 2022

SELL
$16.5 - $30.34 $44,797 - $82,373
-2,715 Reduced 8.7%
28,507 $541,000
Q1 2022

May 16, 2022

BUY
$16.72 - $26.99 $47,752 - $77,083
2,856 Added 10.07%
31,222 $843,000
Q4 2021

Feb 15, 2022

BUY
$16.93 - $26.82 $181,320 - $287,242
10,710 Added 60.66%
28,366 $639,000
Q3 2021

Nov 15, 2021

SELL
$21.86 - $34.77 $67,066 - $106,674
-3,068 Reduced 14.8%
17,656 $463,000
Q2 2021

Aug 16, 2021

SELL
$29.55 - $39.15 $40,779 - $54,027
-1,380 Reduced 6.24%
20,724 $663,000
Q1 2021

May 18, 2021

SELL
$31.52 - $39.28 $819 - $1,021
-26 Reduced 0.12%
22,104 $778,000
Q4 2020

Feb 16, 2021

BUY
$29.88 - $39.8 $8,904 - $11,860
298 Added 1.36%
22,130 $710,000
Q3 2020

Nov 17, 2020

BUY
$34.42 - $43.78 $21,822 - $27,756
634 Added 2.99%
21,832 $821,000
Q2 2020

Aug 17, 2020

BUY
$31.59 - $49.98 $669,644 - $1.06 Million
21,198 New
21,198 $949,000

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.